Dystrophic epidermolysis bullosa: pathogenesis and clinical features.
L Bruckner-Tuderman - Dermatologic clinics, 2010 - europepmc.org
L Bruckner-Tuderman
Dermatologic clinics, 2010•europepmc.orgDystrophic epidermolysis bullosa: pathogenesis and clinical features. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help
Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus
Search life-sciences literature (Over 39 million articles, preprints and more) Search Advanced
search Feedback This website requires cookies, and the limited processing of your personal
data in order to function. By using the site you are agreeing to this as outlined in our privacy …
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help
Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus
Search life-sciences literature (Over 39 million articles, preprints and more) Search Advanced
search Feedback This website requires cookies, and the limited processing of your personal
data in order to function. By using the site you are agreeing to this as outlined in our privacy …
Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.
europepmc.org